EZH2 and head and neck squamous cell carcinoma: As the expression of EZH2 was found to be increased in HNSCC, and the silencing of EZH2 led to the suppression of tumour invasion (Cao et al., 2012), this protein seems to be a promising target for therapies; however its association with PNI has to be evaluated yet.